158 related articles for article (PubMed ID: 20228254)
1. Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo.
Riad A; Westermann D; Escher F; Becher PM; Savvatis K; Lettau O; Heimesaat MM; Bereswill S; Volk HD; Schultheiss HP; Tschöpe C
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2024-31. PubMed ID: 20228254
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
4. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis.
Kim SH; Shin HH; Kim JH; Park JH; Jeon ES; Lim BK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163412
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of interfering TLR9-IRF5 signaling pathway on the development of CVB3-induced myocarditis.
Nie S; Dong B; Gao S; Zhou Y; Lu W; Fang M; Hua S; Yu Y; Wang L
Clin Immunol; 2019 Oct; 207():24-35. PubMed ID: 31279856
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
8. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
9. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis.
Pagni PP; Traub S; Demaria O; Chasson L; Alexopoulou L
Autoimmunity; 2010 Jun; 43(4):275-87. PubMed ID: 20187710
[TBL] [Abstract][Full Text] [Related]
10. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
[TBL] [Abstract][Full Text] [Related]
11. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-Specific Coxsackievirus and Adenovirus Receptor Deletion Enhances Macrophage M1 Polarity in CVB3-Induced Myocarditis.
Shin HH; Jeon ES; Lim BK
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982385
[TBL] [Abstract][Full Text] [Related]
14. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R
Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.
Tschöpe C; Van Linthout S; Jäger S; Arndt R; Trippel T; Müller I; Elsanhoury A; Rutschow S; Anker SD; Schultheiss HP; Pauschinger M; Spillmann F; Pappritz K
ESC Heart Fail; 2020 Oct; 7(5):2838-2852. PubMed ID: 32662949
[TBL] [Abstract][Full Text] [Related]
16. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
[TBL] [Abstract][Full Text] [Related]
17. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
Kaese S; Larbig R; Rohrbeck M; Frommeyer G; Dechering D; Olligs J; Schönhofer-Merl S; Wessely R; Klingel K; Seebohm G; Eckardt L
PLoS One; 2017; 12(6):e0180029. PubMed ID: 28644868
[TBL] [Abstract][Full Text] [Related]
20. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization.
Gou W; Zhang Z; Yang C; Li Y
Exp Cell Res; 2018 May; 366(1):41-48. PubMed ID: 29524390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]